Articoli con mandati relativi all'accesso pubblico - Professor Tamas ReveszUlteriori informazioni
Non disponibili pubblicamente: 7
Neuropathology underlying clinical variability in patients with synucleinopathies
GM Halliday, JL Holton, T Revesz, DW Dickson
Acta neuropathologica 122, 187-204, 2011
Mandati: US National Institutes of Health, Parkinson's UK
Brain amyloid-beta fragment signatures in pathological ageing and Alzheimer's disease by hybrid immunoprecipitation mass spectrometry
E Portelius, T Lashley, A Westerlund, R Persson, NC Fox, K Blennow, ...
Neurodegenerative diseases 15 (1), 50-57, 2015
Mandati: Swedish Research Council, National Institute for Health Research, UK
Minimal change multiple system atrophy: an aggressive variant?
H Ling, YT Asi, IN Petrovic, Z Ahmed, LK Prashanth, LN Hazrati, ...
Movement Disorders 30 (7), 960-967, 2015
Mandati: National Institute for Health Research, UK, Parkinson's UK
The effect of drug treatment on neurogenesis in Parkinson's disease
SS O'Sullivan, M Johnson, DR Williams, T Revesz, JL Holton, AJ Lees, ...
Movement Disorders 26 (1), 45-50, 2011
Mandati: Dunhill Medical Trust, UK
Neuropathological features of multiple system atrophy with cognitive impairment
YT Asi, H Ling, Z Ahmed, AJ Lees, T Revesz, JL Holton
Movement Disorders 29 (7), 884-888, 2014
Mandati: Parkinson's UK
MM2 subtype of sporadic Creutzfeldt-Jakob disease may underlie the clinical presentation of progressive supranuclear palsy
IN Petrovic, A Martin-Bastida, L Massey, H Ling, SS O’Sullivan, ...
Journal of neurology 260, 1031-1036, 2013
Mandati: UK Medical Research Council
A clinicopathologic study of movement disorders in frontotemporal lobar degeneration
E de Pablo‐Fernández, B González‐Herrero, D Cerdán Santacruz, ...
Movement Disorders 36 (3), 632-641, 2021
Mandati: Canadian Institutes of Health Research, Alzheimers's UK, UK Medical Research …
Disponibili pubblicamente: 142
Second consensus statement on the diagnosis of multiple system atrophy
S Gilman, GK Wenning, PA Low, DJ Brooks, CJ Mathias, JQ Trojanowski, ...
Neurology 71 (9), 670-676, 2008
Mandati: US National Institutes of Health
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease
J Neumann, J Bras, E Deas, SS O'Sullivan, L Parkkinen, RH Lachmann, ...
Brain 132 (7), 1783-1794, 2009
Mandati: US National Institutes of Health
Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy
GU Höglinger, NM Melhem, DW Dickson, PMA Sleiman, LS Wang, L Klei, ...
Nature genetics 43 (7), 699-705, 2011
Mandati: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Lewy-and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?
Y Compta, L Parkkinen, SS O'Sullivan, J Vandrovcova, JL Holton, ...
Brain 134 (5), 1493-1505, 2011
Mandati: Parkinson's UK
The heritability and genetics of frontotemporal lobar degeneration
JD Rohrer, R Guerreiro, J Vandrovcova, J Uphill, D Reiman, J Beck, ...
Neurology 73 (18), 1451-1456, 2009
Mandati: US National Institutes of Health, Canadian Institutes of Health Research
Structure-based classification of tauopathies
Y Shi, W Zhang, Y Yang, AG Murzin, B Falcon, A Kotecha, M van Beers, ...
Nature 598 (7880), 359-363, 2021
Mandati: US National Institutes of Health, Alzheimers's UK, UK Biotechnology and …
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson’s disease and multiple system atrophy?
AP Kiely, YT Asi, E Kara, P Limousin, H Ling, P Lewis, C Proukakis, ...
Acta neuropathologica 125, 753-769, 2013
Mandati: UK Medical Research Council, Parkinson's UK, Wellcome Trust
Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations
IRA Mackenzie, M Neumann, EH Bigio, NJ Cairns, I Alafuzoff, J Kril, ...
Acta neuropathologica 117, 15-18, 2009
Mandati: US National Institutes of Health
Loss of VPS13C function in autosomal-recessive parkinsonism causes mitochondrial dysfunction and increases PINK1/Parkin-dependent mitophagy
S Lesage, V Drouet, E Majounie, V Deramecourt, M Jacoupy, A Nicolas, ...
The American Journal of Human Genetics 98 (3), 500-513, 2016
Mandati: US National Institutes of Health, National Institute of Health and Medical …
Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
LA Robak, IE Jansen, J Van Rooij, AG Uitterlinden, R Kraaij, J Jankovic, ...
Brain 140 (12), 3191-3203, 2017
Mandati: US Department of Defense, US National Institutes of Health, Helmholtz …
Unbiased screen for interactors of leucine-rich repeat kinase 2 supports a common pathway for sporadic and familial Parkinson disease
A Beilina, IN Rudenko, A Kaganovich, L Civiero, H Chau, SK Kalia, ...
Proceedings of the National Academy of Sciences 111 (7), 2626-2631, 2014
Mandati: US National Institutes of Health, Research Foundation (Flanders), Fondazione …
Genetics and molecular pathogenesis of sporadic and hereditary cerebral amyloid angiopathies
T Revesz, JL Holton, T Lashley, G Plant, B Frangione, A Rostagno, ...
Acta neuropathologica 118, 115-130, 2009
Mandati: US National Institutes of Health
SNCA variants are associated with increased risk for multiple system atrophy
SW Scholz, H Houlden, C Schulte, M Sharma, A Li, D Berg, A Melchers, ...
Annals of Neurology: Official Journal of the American Neurological …, 2009
Mandati: US National Institutes of Health
Le informazioni sulla pubblicazione e sul finanziamento vengono stabilite automaticamente da un software